551 - 575 of 60.877
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 345,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,85x
- Analysis
- Novo Nordisk Call 405,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,92x
- Analysis
- Novo Nordisk Call 465,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,06x
- Analysis
- Novo Nordisk Call 505,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,42x
- Analysis
- Novo Nordisk Call 495,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,29x
- Analysis
- Novo Nordisk Call 535,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,38x
- Analysis
- Novo Nordisk Call 455,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,37x
- Analysis
- Novo Nordisk Call 515,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,30x
- Analysis
- Novo Nordisk Call 465,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,24x
- Analysis
- Novo Nordisk Call 335,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,18x
- Analysis
- Novo Nordisk Call 305,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,50x
- Analysis
- Novo Nordisk Call 545,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 7,59x
- Analysis
- Novo Nordisk Call 405,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,59x
- Analysis
- Novo Nordisk Call 445,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,36x
- Analysis
- Novo Nordisk Call 485,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,91x
- Analysis
- Novo Nordisk Call 425,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,13x
- Analysis
- Novo Nordisk Call 375,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,68x
- Analysis
- Novo Nordisk Call 345,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,40x
- Analysis
- Novo Nordisk Call 415,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,08x
- Analysis
- Novo Nordisk Call 385,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,83x
- Analysis
- Novo Nordisk Call 365,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,53x
- Analysis
- Novo Nordisk Call 535,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 7,59x
- Analysis
- Novo Nordisk Call 525,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 7,59x
- Analysis
- Novo Nordisk Call 295,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,31x
- Analysis
- Novo Nordisk Call 435,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,95x
- Analysis